Coats' disease: Treatment with intravitreal bevacizumab and laser photocoagulation

Acta Ophthalmologica

Volumn 87, Issue 6, 2009, Pages 687-688

  Stergiou, Panagiotis K ^a   Symeonidis, Chrysanthos ^a   Dimitrakos, Stavros A ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE;

ADOLESCENT; CASE REPORT; EXUDATIVE RETINITIS; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; LETTER; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; EXUDATES AND TRANSUDATES; HUMANS; INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; RETINAL DETACHMENT; RETINAL DISEASES; TELANGIECTASIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 69449102693     PISSN: 1755375X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01253.x     Document Type: Letter

References (5)

1. Haller JA (2004 Coats' disease and retinal telangiectasia. In : Yanoff D Duker JS (eds). Ophthalmology. St Louis, MO : Mosby, 896 901.
2. Minnella AM, Savastano CM, Ziccardi L, Scupola A, Sasso P, Falsini B Balestrazzi E (2008 Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy. Acta Ophthalmol 86 : 683 687.
3. Shields JA, Shields CL, Honavar SG, Demirci H Cater J (2001 Classification and management of Coats' disease: the 2000 Proctor Lecture. Am J Ophthalmol 131 : 572 583.
4. Sivaprasad S, McCluskey P Lightman S (2006 Intravitreal steroids in the management of macular oedema. Acta Ophthalmol Scand 84 : 722 733.
5. Sun Y, Jain A Moshfeghi DM (2007 Elevated vascular endothelial growth factor levels in Coats' disease: rapid response to pegaptanib sodium. Graefes Arch Clin Exp Ophthalmol 245 : 1387 1388.